NCT00633412View on ClinicalTrials.gov

A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US Only

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

February 28, 2001

Study Completion Date

March 31, 2003

Conditions
NSAID Associated Gastric Ulcers
Interventions
DRUG

Esomeprazole

20mg oral daily

DRUG

Ranitidine

150mg oral twice daily

DRUG

Esomeprazole

40mg oral tablet daily

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00633412 - A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US Only | Biotech Hunter | Biotech Hunter